FindTrial
Sign In

survey to rule out the occurrence of dry mouth and related problems in head and neck cancer

A cross-sectional survey to assess prevalence of xerostomia and related problems among patients who have received teletherapy for head and neck cancer in TMH. - PEBRTXP

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2017/04/008372
Enrollment
60
Registered
2017-04-19
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- xersotomia in head and neck cancer

Interventions

None listed

Sponsors

Tata Memorial Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1) Age group: - 18 and above 2) Patients who have received radical external beam radiotherapy (EBRT) with or without concurrent chemotherapy. 3) Those who have completed all planned treatment and have come on their first follow up (8-12 weeks after completion of EBRT. 4) Willing to participate in the study.

Exclusion criteria

Exclusion criteria: 1) Patients receiving adjuvant RT. 2) Patients who have received a combination of EBRT and Brachytherapy or Brachytherapy alone. 3) Metastatic cancer. 4) Co-morbid condition such as DM, antidepressants, Sâ??jogren syndrome.

Design outcomes

Primary

MeasureTime frame
60% prevalence of xerostomia in patients who have received radiation therapy for head and neck cancer by using Groninge xerostomia inventoryTimepoint: February, 2017—

Secondary

MeasureTime frame
50% prevalence of xerostomia related problems such as dental caries, reduced sleep, dysphagia and anorexiaTimepoint: March,2017—

Countries

India

Contacts

Public ContactAnita Dsouza

MNC

poojamurkar93@gmail.com8149809918

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026